Selected research
Market Outlook & Growth Opportunities
Global Cell and Gene Therapy CRO Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Cell and Gene Therapy CRO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell and Gene Therapy CRO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Cell and Gene Therapy CRO Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Cell and Gene Therapy CRO Service market include PPD, Medpace, Labcorp, Veristat, Charles River Laboratories, Premier Research, Catalent, IQVIA and Vial, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Cell and Gene Therapy CRO Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell and Gene Therapy CRO Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell and Gene Therapy CRO Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cell and Gene Therapy CRO Service market.
Cell and Gene Therapy CRO Service Segment by Company
PPD
Medpace
Labcorp
Veristat
Charles River Laboratories
Premier Research
Catalent
IQVIA
Vial
Noble Life Sciences
Ergomed
Cell and Gene Therapy CRO Service Segment by Type
Preclinical CRO
Clinical Stage CRO
Others
Cell and Gene Therapy CRO Service Segment by Application
Hospital
Research Institute
Others
Cell and Gene Therapy CRO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Cell and Gene Therapy CRO Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Cell and Gene Therapy CRO Service key companies, revenue, market share, and recent developments.
3. To split the Cell and Gene Therapy CRO Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Cell and Gene Therapy CRO Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Cell and Gene Therapy CRO Service significant trends, drivers, influence factors in global and regions.
6. To analyze Cell and Gene Therapy CRO Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy CRO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy CRO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy CRO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy CRO Service industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy CRO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Cell and Gene Therapy CRO Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Cell and Gene Therapy CRO Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Cell and Gene Therapy CRO Service Industry Trends
Table 2. Cell and Gene Therapy CRO Service Industry Drivers
Table 3. Cell and Gene Therapy CRO Service Industry Opportunities and Challenges
Table 4. Cell and Gene Therapy CRO Service Industry Restraints
Table 5. Global Cell and Gene Therapy CRO Service Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Cell and Gene Therapy CRO Service Revenue Share by Company (2021-2026)
Table 7. Global Cell and Gene Therapy CRO Service Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Cell and Gene Therapy CRO Service Key Company Manufacturing Base & Headquarters
Table 9. Global Cell and Gene Therapy CRO Service Company, Product Type & Application
Table 10. Global Cell and Gene Therapy CRO Service Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Cell and Gene Therapy CRO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Preclinical CRO
Table 15. Significant Companies of Clinical Stage CRO
Table 16. Significant Companies of Others
Table 17. Global Cell and Gene Therapy CRO Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 18. Global Cell and Gene Therapy CRO Service Sales Value by Type (2021-2026) & (US$ Million)
Table 19. Global Cell and Gene Therapy CRO Service Sales Value by Type (2027-2032) & (US$ Million)
Table 20. Global Cell and Gene Therapy CRO Service Sales Value Share by Type (2021-2026)
Table 21. Global Cell and Gene Therapy CRO Service Sales Value Share by Type (2027-2032)
Table 22. Significant Companies of Hospital
Table 23. Significant Companies of Research Institute
Table 24. Significant Companies of Others
Table 25. Global Cell and Gene Therapy CRO Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Cell and Gene Therapy CRO Service Sales Value by Application (2021-2026) & (US$ Million)
Table 27. Global Cell and Gene Therapy CRO Service Sales Value by Application (2027-2032) & (US$ Million)
Table 28. Global Cell and Gene Therapy CRO Service Sales Value Share by Application (2021-2026)
Table 29. Global Cell and Gene Therapy CRO Service Sales Value Share by Application (2027-2032)
Table 30. Global Cell and Gene Therapy CRO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. Global Cell and Gene Therapy CRO Service Sales Value by Region (2021-2026) & (US$ Million)
Table 32. Global Cell and Gene Therapy CRO Service Sales Value Share by Region (2021-2026)
Table 33. Global Cell and Gene Therapy CRO Service Sales Value by Region (2027-2032) & (US$ Million)
Table 34. Global Cell and Gene Therapy CRO Service Sales Value Share by Region (2027-2032)
Table 35. Global Cell and Gene Therapy CRO Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 36. Global Cell and Gene Therapy CRO Service Sales Value by Country (2021-2026) & (US$ Million)
Table 37. Global Cell and Gene Therapy CRO Service Sales Value Market Share by Country (2021-2026)
Table 38. Global Cell and Gene Therapy CRO Service Sales Value by Country (2027-2032) & (US$ Million)
Table 39. Global Cell and Gene Therapy CRO Service Sales Value Market Share by Country (2027-2032)
Table 40. PPD Company Information
Table 41. PPD Business Overview
Table 42. PPD Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 43. PPD Cell and Gene Therapy CRO Service Product Portfolio
Table 44. PPD Recent Development
Table 45. Medpace Company Information
Table 46. Medpace Business Overview
Table 47. Medpace Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 48. Medpace Cell and Gene Therapy CRO Service Product Portfolio
Table 49. Medpace Recent Development
Table 50. Labcorp Company Information
Table 51. Labcorp Business Overview
Table 52. Labcorp Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Labcorp Cell and Gene Therapy CRO Service Product Portfolio
Table 54. Labcorp Recent Development
Table 55. Veristat Company Information
Table 56. Veristat Business Overview
Table 57. Veristat Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 58. Veristat Cell and Gene Therapy CRO Service Product Portfolio
Table 59. Veristat Recent Development
Table 60. Charles River Laboratories Company Information
Table 61. Charles River Laboratories Business Overview
Table 62. Charles River Laboratories Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 63. Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio
Table 64. Charles River Laboratories Recent Development
Table 65. Premier Research Company Information
Table 66. Premier Research Business Overview
Table 67. Premier Research Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Premier Research Cell and Gene Therapy CRO Service Product Portfolio
Table 69. Premier Research Recent Development
Table 70. Catalent Company Information
Table 71. Catalent Business Overview
Table 72. Catalent Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Catalent Cell and Gene Therapy CRO Service Product Portfolio
Table 74. Catalent Recent Development
Table 75. IQVIA Company Information
Table 76. IQVIA Business Overview
Table 77. IQVIA Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. IQVIA Cell and Gene Therapy CRO Service Product Portfolio
Table 79. IQVIA Recent Development
Table 80. Vial Company Information
Table 81. Vial Business Overview
Table 82. Vial Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Vial Cell and Gene Therapy CRO Service Product Portfolio
Table 84. Vial Recent Development
Table 85. Noble Life Sciences Company Information
Table 86. Noble Life Sciences Business Overview
Table 87. Noble Life Sciences Cell and Gene Therapy CRO Service Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio
Table 89. Noble Life Sciences Recent Development
Table 90. Ergomed Company Information
Table 91. Ergomed Business Overview
Table 92. Ergomed Cell and Gene Therapy CRO Service Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Ergomed Cell and Gene Therapy CRO Service Product Portfolio
Table 94. Ergomed Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Authors List of This Report
Table 97. Secondary Sources
Table 98. Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy CRO Service Product Image
Figure 2. Global Cell and Gene Therapy CRO Service Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cell and Gene Therapy CRO Service Market Size (2021-2032) & (US$ Million)
Figure 4. Global Cell and Gene Therapy CRO Service Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Preclinical CRO Image
Figure 8. Clinical Stage CRO Image
Figure 9. Others Image
Figure 10. Global Cell and Gene Therapy CRO Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global Cell and Gene Therapy CRO Service Sales Value Share 2021 VS 2025 VS 2032
Figure 12. Global Cell and Gene Therapy CRO Service Sales Value Share by Type (2021-2032)
Figure 13. Hospital Image
Figure 14. Research Institute Image
Figure 15. Others Image
Figure 16. Global Cell and Gene Therapy CRO Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 17. Global Cell and Gene Therapy CRO Service Sales Value Share 2021 VS 2025 VS 2032
Figure 18. Global Cell and Gene Therapy CRO Service Sales Value Share by Application (2021-2032)
Figure 19. Global Cell and Gene Therapy CRO Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 20. Global Cell and Gene Therapy CRO Service Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 21. North America Cell and Gene Therapy CRO Service Sales Value (2021-2032) & (US$ Million)
Figure 22. North America Cell and Gene Therapy CRO Service Sales Value Share by Country (%), 2025 VS 2032
Figure 23. Europe Cell and Gene Therapy CRO Service Sales Value (2021-2032) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy CRO Service Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Asia-Pacific Cell and Gene Therapy CRO Service Sales Value (2021-2032) & (US$ Million)
Figure 26. Asia-Pacific Cell and Gene Therapy CRO Service Sales Value Share by Country (%), 2025 VS 2032
Figure 27. South America Cell and Gene Therapy CRO Service Sales Value (2021-2032) & (US$ Million)
Figure 28. South America Cell and Gene Therapy CRO Service Sales Value Share by Country (%), 2025 VS 2032
Figure 29. Middle East & Africa Cell and Gene Therapy CRO Service Sales Value (2021-2032) & (US$ Million)
Figure 30. Middle East & Africa Cell and Gene Therapy CRO Service Sales Value Share by Country (%), 2025 VS 2032
Figure 31. USA Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 32. USA Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 33. USA Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 34. Canada Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 35. Canada Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 36. Canada Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 37. Mexico Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 38. Mexico Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 39. Mexico Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 40. Germany Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. Germany Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. Germany Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. France Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. France Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. France Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. U.K. Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. U.K. Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. U.K. Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Italy Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Italy Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Italy Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. Spain Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. Spain Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. Spain Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. Russia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. Russia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. Russia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Netherlands Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Netherlands Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Netherlands Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Nordic Countries Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Nordic Countries Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Nordic Countries Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. China Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. China Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. China Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Japan Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Japan Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Japan Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. South Korea Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. South Korea Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. South Korea Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. India Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. India Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. India Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Australia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Australia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Australia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. Southeast Asia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. Southeast Asia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. Southeast Asia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. Brazil Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. Brazil Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. Brazil Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Argentina Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Argentina Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Argentina Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Chile Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Chile Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Chile Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Colombia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Colombia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Colombia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Peru Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Peru Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Peru Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Israel Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Israel Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Israel Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. UAE Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. UAE Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. UAE Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Turkey Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Turkey Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Turkey Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Iran Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Iran Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Iran Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. Egypt Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. Egypt Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. Egypt Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Years Considered
Figure 116. Research Process
Figure 117. Key Executives Interviewed
Scope & coverage.
Types
- Preclinical CRO
- Clinical Stage CRO
- Others
Applications
- Hospital
- Research Institute
- Others
Companies covered
- PPD
- Medpace
- Labcorp
- Veristat
- Charles River Laboratories
- Premier Research
- Catalent
- IQVIA
- Vial
- Noble Life Sciences
- Ergomed
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cell and Gene Therapy CRO Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cell and Gene Therapy CRO Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Cell and Gene Therapy CRO Service Market Dynamics
- 2.1 Cell and Gene Therapy CRO Service Industry Trends
- 2.2 Cell and Gene Therapy CRO Service Industry Drivers
- 2.3 Cell and Gene Therapy CRO Service Industry Opportunities and Challenges
- 2.4 Cell and Gene Therapy CRO Service Industry Restraints
3 Cell and Gene Therapy CRO Service Market by Company
- 3.1 Global Cell and Gene Therapy CRO Service Company Revenue Ranking in 2025
- 3.2 Global Cell and Gene Therapy CRO Service Revenue by Company (2021-2026)
- 3.3 Global Cell and Gene Therapy CRO Service Company Ranking (2024-2026)
- 3.4 Global Cell and Gene Therapy CRO Service Company Manufacturing Base and Headquarters
- 3.5 Global Cell and Gene Therapy CRO Service Company Product Type and Application
- 3.6 Global Cell and Gene Therapy CRO Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Cell and Gene Therapy CRO Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Cell and Gene Therapy CRO Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Cell and Gene Therapy CRO Service Market by Type
- 4.1 Cell and Gene Therapy CRO Service Type Introduction
- 4.1.1 Preclinical CRO
- 4.1.2 Clinical Stage CRO
- 4.1.3 Others
- 4.2 Global Cell and Gene Therapy CRO Service Sales Value by Type
- 4.2.1 Global Cell and Gene Therapy CRO Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cell and Gene Therapy CRO Service Sales Value by Type (2021-2032)
- 4.2.3 Global Cell and Gene Therapy CRO Service Sales Value Share by Type (2021-2032)
5 Cell and Gene Therapy CRO Service Market by Application
- 5.1 Cell and Gene Therapy CRO Service Application Introduction
- 5.1.1 Hospital
- 5.1.2 Research Institute
- 5.1.3 Others
- 5.2 Global Cell and Gene Therapy CRO Service Sales Value by Application
- 5.2.1 Global Cell and Gene Therapy CRO Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cell and Gene Therapy CRO Service Sales Value by Application (2021-2032)
- 5.2.3 Global Cell and Gene Therapy CRO Service Sales Value Share by Application (2021-2032)
6 Cell and Gene Therapy CRO Service Regional Value Analysis
- 6.1 Global Cell and Gene Therapy CRO Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cell and Gene Therapy CRO Service Sales Value by Region (2021-2032)
- 6.2.1 Global Cell and Gene Therapy CRO Service Sales Value by Region: 2021-2026
- 6.2.2 Global Cell and Gene Therapy CRO Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cell and Gene Therapy CRO Service Sales Value (2021-2032)
- 6.3.2 North America Cell and Gene Therapy CRO Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Cell and Gene Therapy CRO Service Sales Value (2021-2032)
- 6.4.2 Europe Cell and Gene Therapy CRO Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Cell and Gene Therapy CRO Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Cell and Gene Therapy CRO Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Cell and Gene Therapy CRO Service Sales Value (2021-2032)
- 6.6.2 South America Cell and Gene Therapy CRO Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Cell and Gene Therapy CRO Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Cell and Gene Therapy CRO Service Sales Value Share by Country, 2025 VS 2032
7 Cell and Gene Therapy CRO Service Country-level Value Analysis
- 7.1 Global Cell and Gene Therapy CRO Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Cell and Gene Therapy CRO Service Sales Value by Country (2021-2032)
- 7.2.1 Global Cell and Gene Therapy CRO Service Sales Value by Country (2021-2026)
- 7.2.2 Global Cell and Gene Therapy CRO Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Cell and Gene Therapy CRO Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Cell and Gene Therapy CRO Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Cell and Gene Therapy CRO Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 PPD
- 8.1.1 PPD Company Information
- 8.1.2 PPD Business Overview
- 8.1.3 PPD Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.1.4 PPD Cell and Gene Therapy CRO Service Product Portfolio
- 8.1.5 PPD Recent Developments
- 8.2 Medpace
- 8.2.1 Medpace Company Information
- 8.2.2 Medpace Business Overview
- 8.2.3 Medpace Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Medpace Cell and Gene Therapy CRO Service Product Portfolio
- 8.2.5 Medpace Recent Developments
- 8.3 Labcorp
- 8.3.1 Labcorp Company Information
- 8.3.2 Labcorp Business Overview
- 8.3.3 Labcorp Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Labcorp Cell and Gene Therapy CRO Service Product Portfolio
- 8.3.5 Labcorp Recent Developments
- 8.4 Veristat
- 8.4.1 Veristat Company Information
- 8.4.2 Veristat Business Overview
- 8.4.3 Veristat Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Veristat Cell and Gene Therapy CRO Service Product Portfolio
- 8.4.5 Veristat Recent Developments
- 8.5 Charles River Laboratories
- 8.5.1 Charles River Laboratories Company Information
- 8.5.2 Charles River Laboratories Business Overview
- 8.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio
- 8.5.5 Charles River Laboratories Recent Developments
- 8.6 Premier Research
- 8.6.1 Premier Research Company Information
- 8.6.2 Premier Research Business Overview
- 8.6.3 Premier Research Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Premier Research Cell and Gene Therapy CRO Service Product Portfolio
- 8.6.5 Premier Research Recent Developments
- 8.7 Catalent
- 8.7.1 Catalent Company Information
- 8.7.2 Catalent Business Overview
- 8.7.3 Catalent Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Catalent Cell and Gene Therapy CRO Service Product Portfolio
- 8.7.5 Catalent Recent Developments
- 8.8 IQVIA
- 8.8.1 IQVIA Company Information
- 8.8.2 IQVIA Business Overview
- 8.8.3 IQVIA Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.8.4 IQVIA Cell and Gene Therapy CRO Service Product Portfolio
- 8.8.5 IQVIA Recent Developments
- 8.9 Vial
- 8.9.1 Vial Company Information
- 8.9.2 Vial Business Overview
- 8.9.3 Vial Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Vial Cell and Gene Therapy CRO Service Product Portfolio
- 8.9.5 Vial Recent Developments
- 8.10 Noble Life Sciences
- 8.10.1 Noble Life Sciences Company Information
- 8.10.2 Noble Life Sciences Business Overview
- 8.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio
- 8.10.5 Noble Life Sciences Recent Developments
- 8.11 Ergomed
- 8.11.1 Ergomed Company Information
- 8.11.2 Ergomed Business Overview
- 8.11.3 Ergomed Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Ergomed Cell and Gene Therapy CRO Service Product Portfolio
- 8.11.5 Ergomed Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst